Good - #Pharma is refocusing on the antibiotics space.

"Several big drug makers are creating a new $1 billion for-profit venture to acquire or invest in small antibiotic companies and their nascent products."

$PFE $MRK $LLY $NVO $BAYN $MKGAF @Boehringer

https://t.co/P6pNor4kLU